159 related articles for article (PubMed ID: 35746971)
1. Immunolocalization of kappa opioid receptors in the axon initial segment of a group of embryonic mesencephalic dopamine neurons.
Escobar AP; Meza RC; Gonzalez M; Henny P; Andrés ME
IBRO Neurosci Rep; 2022 Jun; 12():411-418. PubMed ID: 35746971
[TBL] [Abstract][Full Text] [Related]
2. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors.
Escobar ADP; Casanova JP; Andrés ME; Fuentealba JA
Front Pharmacol; 2020; 11():57. PubMed ID: 32132923
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.
Garzón M; Duffy AM; Chan J; Lynch MK; Mackie K; Pickel VM
Neuroscience; 2013 Nov; 252():126-43. PubMed ID: 23954803
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2.
Perreault ML; Fan T; Alijaniaram M; O'Dowd BF; George SR
PLoS One; 2012; 7(3):e33348. PubMed ID: 22428025
[TBL] [Abstract][Full Text] [Related]
6. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
Pickel VM; Chan J; Nirenberg MJ
Synapse; 2002 Aug; 45(2):113-24. PubMed ID: 12112404
[TBL] [Abstract][Full Text] [Related]
7. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.
Krabbe S; Duda J; Schiemann J; Poetschke C; Schneider G; Kandel ER; Liss B; Roeper J; Simpson EH
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1498-506. PubMed ID: 25675529
[TBL] [Abstract][Full Text] [Related]
8. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.
Chefer VI; Bäckman CM; Gigante ED; Shippenberg TS
Neuropsychopharmacology; 2013 Dec; 38(13):2623-31. PubMed ID: 23921954
[TBL] [Abstract][Full Text] [Related]
9. Cocaine self-administration augments kappa opioid receptor system-mediated inhibition of dopamine activity in the mesolimbic dopamine system.
Estave PM; Sun H; Peck EG; Holleran KM; Chen R; Jones SR
IBRO Neurosci Rep; 2023 Jun; 14():129-137. PubMed ID: 36748012
[TBL] [Abstract][Full Text] [Related]
10. Striatal-enriched protein tyrosine phosphatase regulates dopaminergic neuronal development via extracellular signal-regulated kinase signaling.
Kim SY; Lee HJ; Kim YN; Yoon S; Lee JE; Sun W; Choi EJ; Baik JH
Exp Neurol; 2008 Nov; 214(1):69-77. PubMed ID: 18708052
[TBL] [Abstract][Full Text] [Related]
11. Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen.
Brené S; Lindefors N; Herrera-Marschitz M; Persson H
Exp Brain Res; 1990; 83(1):96-104. PubMed ID: 2150048
[TBL] [Abstract][Full Text] [Related]
12. Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats.
Perreault ML; Hasbi A; Alijaniaram M; O'Dowd BF; George SR
Neuroscience; 2012 Dec; 225():130-9. PubMed ID: 22986162
[TBL] [Abstract][Full Text] [Related]
13. Learned avoidance requires VTA KOR-mediated reductions in dopamine.
Robble MA; Bozsik ME; Wheeler DS; Wheeler RA
Neuropharmacology; 2020 May; 167():107996. PubMed ID: 32057802
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.
Sesack SR; Aoki C; Pickel VM
J Neurosci; 1994 Jan; 14(1):88-106. PubMed ID: 7904306
[TBL] [Abstract][Full Text] [Related]
15. Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles.
Svingos AL; Chavkin C; Colago EE; Pickel VM
Synapse; 2001 Dec; 42(3):185-92. PubMed ID: 11746715
[TBL] [Abstract][Full Text] [Related]
16. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell.
Delle Donne KT; Chan J; Boudin H; Pélaprat D; Rostène W; Pickel VM
Synapse; 2004 Jun; 52(3):176-87. PubMed ID: 15065218
[TBL] [Abstract][Full Text] [Related]
17. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
18. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.
Anzalone A; Lizardi-Ortiz JE; Ramos M; De Mei C; Hopf FW; Iaccarino C; Halbout B; Jacobsen J; Kinoshita C; Welter M; Caron MG; Bonci A; Sulzer D; Borrelli E
J Neurosci; 2012 Jun; 32(26):9023-34. PubMed ID: 22745501
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W; Ding S; Zhou FM
J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
[TBL] [Abstract][Full Text] [Related]
20. Nucleus Accumbens Microcircuit Underlying D2-MSN-Driven Increase in Motivation.
Soares-Cunha C; Coimbra B; Domingues AV; Vasconcelos N; Sousa N; Rodrigues AJ
eNeuro; 2018; 5(2):. PubMed ID: 29780881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
